Jones Criteria for Acute Rheumatic Fever Diagnosis
Modified Jones Criteria (2015 AHA) for diagnosing first episode of acute rheumatic fever (ARF). Requires evidence of preceding streptococcal infection PLUS major/minor criteria as specified.
Score interpretation
Jones Criteria not fulfilled for ARF
→ Consider alternative diagnoses (reactive arthritis, JIA, septic arthritis, SLE, Lyme disease); treat any confirmed GAS infection with amoxicillin or penicillin V; follow-up ESR, ASO titre
Jones Criteria points present — apply 2 major / 1 major + 2 minor / 3 minor rule
→ If strep evidence AND criteria met: ARF diagnosed. Admit for monitoring. Benzylpenicillin 1.2 MU IM stat + penicillin V oral × 10 days. Aspirin for arthritis (80–100 mg/kg/day). Prednisolone for severe carditis. Echo mandatory if carditis suspected. Secondary prophylaxis: phenoxymethylpenicillin/benzathine penicillin (duration based on carditis severity: 5 years to lifelong); cardiology and rheumatology follow-up
Interpretation bands for the Jones Criteria. Apply clinical judgement and local guidance.
References
- Gewitz MH et al. Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography. Circulation. 2015;131(20):1806–1818.
Related
Curated clinical cross-links plus same-class fallbacks.
- Benzathine Benzylpenicillin · Long-Acting Penicillin — Syphilis / Rheumatic Fever Prophylaxis
- Glyceryl Trinitrate (Sublingual / IV) · Nitrate / Acute Angina
- Dobutamine (Acute HF / Stress Echo) · Inotrope / Acute Heart Failure
- Milrinone · Inodilator / Acute Heart Failure
- Azathioprine · Systemic Immunosuppressant — Eczema / Autoimmune Dermatoses
- Mycophenolate Mofetil · Systemic Immunosuppressant — Bullous Diseases / Autoimmune Dermatoses
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.